Generated May 26, 2026 at 3:29 PM ET
· Covers May 26 trading day
· 10 of 104 ready 8-Ks selected
· AI-assisted overview
Several companies reported key regulatory and corporate developments. Outlook Therapeutics received FDA approval for its appeal on LYTENAVA for nAMD and will resubmit its BLA in June. Cartesian Therapeutics secured up to $150 million in debt financing, while Northern Oil & Gas entered Canada with a CA$350 million Duvernay acquisition and raised its production guidance. Dropbox appointed Ashraf Alkarmi as co-CEO with Drew Houston moving to Executive Chairman, and Corbus Pharmaceuticals reported positive Phase 2 data for CRB-701, planning a registrational study this summer. Additional filings included TeraWulf's acquisition of a 1+ GW data center campus, Wheels Up closing a $68 million equipment facility with Delta extending its lock-up, and Focus Universal and Microbot Medical each achieving regulatory compliance milestones.
leadership
neutral
materiality 0.80
May 26, 2026 13:15 UTC
Dropbox appoints Ashraf Alkarmi as co-CEO; Drew Houston to become Executive Chairman; Q2/FY26 guidance reaffirmed
- Ashraf Alkarmi, previously GM Core, appointed co-CEO effective May 26, 2026; will become sole CEO after transition; Drew Houston to become Executive Chairman.
- Alkarmi receives $825k base salary, 100% target bonus, and RSUs valued at $12.656M vesting over four years.
- Michael Torres appointed Chief Product Officer effective July 7, 2026; previously VP Product at Alphabet/Chrome and VP/GM Kindle at Amazon.
OTLK
Outlook Therapeutics, Inc.
regulatory
positive
materiality 0.85
May 26, 2026 11:15 UTC
FDA grants Outlook Therapeutics appeal; BLA resubmission planned for June 2026
- FDA concluded substantial evidence of effectiveness for LYTENAVA (bevacizumab-vikg) for nAMD after FDR appeal.
- Company will resubmit BLA as Class 1 in June 2026; PDUFA decision expected within 60 days.
- Appeal resolves December 30, 2025 Complete Response Letter; FDA directs final labeling discussions.
m_and_a
positive
materiality 0.75
May 26, 2026 12:06 UTC
TeraWulf acquires 1+ GW hyperscale AI/HPC campus in Eastern Kentucky (Muskie Data Campus)
- Acquired 285-acre Muskie Data Campus in Eastern Kentucky from Industrial Equity Partners; closed May 22, 2026.
- Site expected to support over 1 GW data center capacity; initial 500 MW in H2 2028, additional 500 MW in H2 2030.
- Kentucky Power (AEP) building 345 kV substation connected to 765 kV network; long-term power agreements executed.
FCUV
FOCUS UNIVERSAL INC.
regulatory
positive
materiality 0.70
May 26, 2026 19:19 UTC
Focus Universal regains Nasdaq equity compliance after Series B conversion and $4M warrant offering
- Company now believes it meets Nasdaq's $2.5M stockholders' equity minimum under Listing Rule 5550(b)(1).
- Majority holders converted 5,216 Series B shares into 665,328 common shares on April 6, 2026.
- Remaining Series B shares redeemed for $961,860 at $782/share; no Series B shares outstanding as of May 14, 2026.
MBOT
Microbot Medical Inc.
regulatory
positive
materiality 0.70
May 26, 2026 12:30 UTC
Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.
- Israeli Ministry of Health's AMAR Division grants marketing clearance for LIBERTY Endovascular Robotic System in Israel.
- First regulatory approval outside the U.S.; enables Free Sale Certificate for submissions in other jurisdictions.
- Company targets CE Mark certification by end of 2026 for EU market expansion.
RNAC
Cartesian Therapeutics, Inc.
debt
positive
materiality 0.85
May 26, 2026 11:08 UTC
Cartesian secures up to $150M debt facility; CMO resigns; Phase 3 data expected Q1 2027
- Secured up to $150M credit facility with K2 HealthVentures; initial $50M tranche funded at close on May 22, 2026.
- Term loans bear interest at 8.95% or prime+2.20% (whichever greater); matures June 1, 2030 with monthly amortization from July 2029.
- CMO Milos Miljkovic resigns effective May 31, 2026; will receive severance including six months' salary and COBRA coverage.
m_and_a
positive
materiality 0.65
May 26, 2026 17:38 UTC
AMETEK completes acquisition of First Aviation Services; ~$80M revenue
- First Aviation Services generates ~$80M in annual revenue and operates six U.S. centers of excellence.
- First Aviation provides MRO for advanced electronics, rotor blades, propellers, landing gear, and flight controls.
- Acquisition is a strategic fit, expanding AMETEK's MRO capabilities in defense and aerospace.
NOG
NORTHERN OIL & GAS, INC.
m_and_a
positive
materiality 0.85
May 26, 2026 10:39 UTC
NOG enters Canada with CA$350M Duvernay acquisition; raises FY2026 production guidance
- Acquires 25% non-operated stake in Duvernay light oil assets for CA$350M (~US$259M); CA$113M in NOG stock plus CA$237M cash.
- Assets include ~4,000 Boe/d (80% light oil), 75,000 net acres, ~500 gross locations with <$50 WTI breakevens.
- Effective date April 1, 2026; expected close late Q2 2026; long-term joint development agreement with Parallax.
UP
Wheels Up Experience Inc.
debt
positive
materiality 0.75
May 26, 2026 10:57 UTC
Delta extends lock-up on 35.6% stake through May 2027; Wheels Up closes $68M equipment facility
- Delta extended lock-up on all its shares of Wheels Up common stock through May 22, 2027; shares represent ~35.6% of outstanding.
- Closed $68M Series B Revolving Equipment Notes Facility, net proceeds ~$64.3M.
- Total borrowing capacity under Revolving Equipment Notes Facilities increased to $400M.
CRBP
Corbus Pharmaceuticals Holdings, Inc.
other_material
positive
materiality 0.85
May 26, 2026 12:56 UTC
Corbus reports CRB-701 42.9% cORR in 2L OPSCC at 3.6 mg/kg; registrational study planned summer 2026
- cORR 42.9% (9/21) in 2L OPSCC at 3.6 mg/kg; median DOR 6.3 mo, PFS 5.6 mo.
- cORR 34.4% (11/32) in 2L cervical cancer at 3.6 mg/kg; 2 complete responses, DOR 8.0 mo.
- Safety: treatment discontinuations 2.8%; no Grade 5 events; ocular AEs manageable.